UBS Group’s Epizyme, Inc EPZM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
Sell
-66,512
Closed -$98K 10480
2022
Q2
$98K Buy
66,512
+65,012
+4,334% +$95.8K ﹤0.01% 4458
2022
Q1
$2K Hold
1,500
﹤0.01% 8748
2021
Q4
$4K Sell
1,500
-38,902
-96% -$104K ﹤0.01% 8495
2021
Q3
$207K Buy
40,402
+38,902
+2,593% +$199K ﹤0.01% 4246
2021
Q2
$12K Sell
1,500
-118,099
-99% -$945K ﹤0.01% 6831
2021
Q1
$1.04M Buy
119,599
+117,639
+6,002% +$1.02M ﹤0.01% 3321
2020
Q4
$21K Sell
1,960
-500
-20% -$5.36K ﹤0.01% 5916
2020
Q3
$29K Buy
2,460
+960
+64% +$11.3K ﹤0.01% 5175
2020
Q2
$24K Sell
1,500
-2,898
-66% -$46.4K ﹤0.01% 5602
2020
Q1
$68K Sell
4,398
-21,630
-83% -$334K ﹤0.01% 4715
2019
Q4
$640K Sell
26,028
-146,676
-85% -$3.61M ﹤0.01% 3697
2019
Q3
$1.78M Buy
172,704
+79,977
+86% +$825K ﹤0.01% 2715
2019
Q2
$1.16M Buy
92,727
+39,978
+76% +$501K ﹤0.01% 2941
2019
Q1
$654K Sell
52,749
-218,091
-81% -$2.7M ﹤0.01% 3194
2018
Q4
$1.67M Buy
270,840
+176,853
+188% +$1.09M ﹤0.01% 2584
2018
Q3
$997K Buy
93,987
+9,484
+11% +$101K ﹤0.01% 3153
2018
Q2
$1.15M Sell
84,503
-30,237
-26% -$410K ﹤0.01% 2969
2018
Q1
$2.04M Buy
114,740
+102,620
+847% +$1.82M ﹤0.01% 2540
2017
Q4
$152K Sell
12,120
-23,790
-66% -$298K ﹤0.01% 4187
2017
Q3
$684K Buy
35,910
+22,833
+175% +$435K ﹤0.01% 3248
2017
Q2
$197K Buy
13,077
+10,525
+412% +$159K ﹤0.01% 3901
2017
Q1
$44K Sell
2,552
-8,125
-76% -$140K ﹤0.01% 4711
2016
Q4
$129K Buy
10,677
+6,912
+184% +$83.5K ﹤0.01% 4239
2016
Q3
$37K Buy
3,765
+636
+20% +$6.25K ﹤0.01% 4889
2016
Q2
$32K Buy
3,129
+179
+6% +$1.83K ﹤0.01% 5024
2016
Q1
$36K Sell
2,950
-37,441
-93% -$457K ﹤0.01% 4950
2015
Q4
$647K Buy
40,391
+37,441
+1,269% +$600K ﹤0.01% 2979
2015
Q3
$38K Sell
2,950
-679
-19% -$8.75K ﹤0.01% 4921
2015
Q2
$87K Buy
3,629
+479
+15% +$11.5K ﹤0.01% 4389
2015
Q1
$59K Buy
3,150
+488
+18% +$9.14K ﹤0.01% 4546
2014
Q4
$50K Buy
+2,662
New +$50K ﹤0.01% 4723